Oruka Therapeutics, Inc. short interest in 2025
In 2025, Oruka Therapeutics, Inc.'s disclosed short interest ran from 5.34% of shares outstanding on 15 Jan 2025 to 15.75% on 31 Dec 2025, a change of +10.41 percentage points. The year's high was 15.75% on 31 Dec 2025 and its low 4.33% on 31 Mar 2025, averaging 8.55% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 28.33 days on 15 Aug 2025. Full history: Oruka Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 5.34% (15 Jan 2025)
- End of year
- 15.75% (31 Dec 2025)
- Change
- +10.41 pp
- High
- 15.75% (31 Dec 2025)
- Low
- 4.33% (31 Mar 2025)
- Average
- 8.55%
- Highest days to cover
- 28.33 (15 Aug 2025)
- SEC filings marked
- 4
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 5.34% | 5.70 | |
| 31 Jan 2025 | 4.87% | 6.17 | |
| 14 Feb 2025 | 5.03% | 5.99 | |
| 28 Feb 2025 | 5.72% | 8.26 | |
| 14 Mar 2025 | 4.42% | 7.35 | 10-K filed |
| 31 Mar 2025 | 4.33% | 7.09 | |
| 15 Apr 2025 | 6.75% | 4.50 | |
| 30 Apr 2025 | 7.12% | 14.46 | |
| 15 May 2025 | 7.26% | 21.90 | 10-Q filed |
| 30 May 2025 | 7.37% | 17.59 | |
| 13 Jun 2025 | 7.48% | 19.14 | |
| 30 Jun 2025 | 11.02% | 8.03 | |
| 15 Jul 2025 | 10.19% | 18.66 | |
| 31 Jul 2025 | 8.97% | 23.47 | |
| 15 Aug 2025 | 11.49% | 28.33 | 10-Q filed |
| 29 Aug 2025 | 8.54% | 23.56 | |
| 15 Sep 2025 | 8.19% | 22.42 | |
| 30 Sep 2025 | 9.65% | 4.94 | |
| 15 Oct 2025 | 10.67% | 6.92 | |
| 31 Oct 2025 | 10.76% | 17.29 | |
| 14 Nov 2025 | 10.84% | 11.21 | 10-Q filed |
| 28 Nov 2025 | 11.36% | 13.13 | |
| 15 Dec 2025 | 12.04% | 14.27 | |
| 31 Dec 2025 | 15.75% | 8.43 |
See also: Oruka Therapeutics, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.